INTERNATIONAL PATENT: RESANO GMBH, BIONTECH SE, UNIVERSITAT STUTTGART FILES APPLICATION FOR "TNF RECEPTOR 2-SPECIFIC AGONIST FUSION PROTEINS COMPRISING TNF HOMOLOGY DOMAINS AND MUTATED FC DOMAINS"

GENEVA, April 6 -- RESANO GMBH (An der Goldgrube 1255131 Mainz), BIONTECH SE (An der Goldgrube 1255131 Mainz), UNIVERSITAT STUTTGART (Keplerstrasse 770174 Stuttgart) filed a patent application (PCT/EP2024/077361) for "TNF RECEPTOR 2-SPECIFIC AGONIST FUSION PROTEINS COMPRISING TNF HOMOLOGY DOMAINS AND MUTATED FC DOMAINS" on Sep 27, 2024. With publication no. WO/2025/068565, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FISCHER, Roman (c/o reSano GmbHAn der Goldgrube 1255131 Mainz), SAHIN, Ugur (c/o BioNTech SEAn der Gold...